Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Board/Management Information 2024

May 8, 2024

5262_mang_2024-05-08_4bf7a72e-bcfb-46ca-a9a6-1d797d7e5215.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 6783N

GSK PLC

08 May 2024

GSK plc

Board Committee Change

GSK plc today announces the following changes to its Board Committee membership:

Wendy Becker has been appointed as a member of the Corporate Responsibility Committee with effect from 7 May 2024. As previously announced, Wendy succeeded Urs Rohner as Chair of the Remuneration Committee following his retirement from the Board at the conclusion of the 2024 Annual General Meeting held today.

These changes are in addition to Wendy's membership of the Audit & Risk Committee.

V A Whyte

Company Secretary

8 May 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAEASSPESLLEFA